Brief: Neurovive Gets Positive FDA Feedback On Neurostat TBI Development Plan

Abliva AB

06/09/2018 07:33

Sept 6 (Reuters) - NeuroVive Pharmaceutical AB  NVP.ST :
    * NEUROVIVE RECEIVES POSITIVE FDA FEEDBACK ON ITS NEUROSTAT TBI DEVELOPMENT PLAN

Source text for Eikon:  ID:nWkrbqnxZm 
Further company coverage:  NVP.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))